Phenotype and kinetics of SARS-CoV-2–specific T cells in COVID-19 patients with acute respiratory distress syndrome-Reference-Cited by-同舟云学术

Phenotype and kinetics of SARS-CoV-2–specific T cells in COVID-19 patients with acute respiratory distress syndrome

Published:2020-06-26 Issue:48 Volume:5 Page:
ISSN:2470-9468
Container-title:Science Immunology
language:en
Short-container-title:Sci. Immunol.

Author:

Weiskopf Daniela¹^ORCID,Schmitz Katharina S.²^ORCID,Raadsen Matthijs P.²,Grifoni Alba¹,Okba Nisreen M. A.²^ORCID,Endeman Henrik³,van den Akker Johannes P. C.³^ORCID,Molenkamp Richard²^ORCID,Koopmans Marion P. G.²^ORCID,van Gorp Eric C. M.²,Haagmans Bart L.²^ORCID,de Swart Rik L.²^ORCID,Sette Alessandro¹⁴⁵^ORCID,de Vries Rory D.²^ORCID

Affiliation:

1. Center for Infectious Disease, La Jolla Institute for Immunology, La Jolla, CA 92037, USA.

2. Department of Viroscience, Erasmus MC, Rotterdam, the Netherlands.

3. Department of Intensive Care, Erasmus MC, Rotterdam, the Netherlands.

4. Department of Pathology, University of California, San Diego, CA 92037, USA.

5. Department of Medicine, University of California, San Diego, CA 92037, USA.

Abstract

Peptide pool stimulation enables longitudinal analysis of SARS-CoV-2–specific CD4 + and CD8 + T cells in ICU-admitted COVID-19 patients.

Funder

National Institutes of Health

European Union’s Horizon 2020

Publisher